UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher

Oral oncology, 2020-02, Vol.101, p.104492-104492, Article 104492

2020

Volltextzugriff (PDF)

Management of locally recurrent nasopharyngeal carcinoma

Cancer treatment reviews, 2019-09, Vol.79, p.101890-101890, Article 101890

2019

Volltextzugriff (PDF)

Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum‐based therapies

Cancer, 2008-06, Vol.112 (12), p.2710-2719

2008

Volltextzugriff (PDF)

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data

The oncologist (Dayton, Ohio), 2017-09, Vol.22 (9), p.1056-1066

2017

Volltextzugriff (PDF)

Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group

Journal of clinical oncology, 2013-08, Vol.31 (23), p.2854-2860

2013

Volltextzugriff (PDF)

Editorial: Head and neck cancer in the elderly

Frontiers in oncology, 2023-06, Vol.13, p.1218274-1218274

2023

Volltextzugriff (PDF)

Editorial: Insights in head and neck cancer: 2021

Frontiers in oncology, 2023-03, Vol.13, p.1180965-1180965

2023

Volltextzugriff (PDF)

Oligometastatic Cancer: Key Concepts and Research Opportunities for 2021 and Beyond

Cancers, 2021-05, Vol.13 (11), p.2518

2021

Volltextzugriff (PDF)

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2171-2177

2007

Volltextzugriff (PDF)

Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice

Frontiers in oncology, 2019-06, Vol.9, p.464-464

2019

Volltextzugriff (PDF)

A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy

The oncologist (Dayton, Ohio), 2010-07, Vol.15 (7), p.699-731

2010

Volltextzugriff (PDF)

Oligometastatic Disease Management: Finding the Sweet Spot

Frontiers in oncology, 2020-12, Vol.10, p.617793

2020

Volltextzugriff (PDF)

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

Frontiers in oncology, 2019-02, Vol.9, p.86-86

2019

Volltextzugriff (PDF)

Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer

Journal of clinical oncology, 2010-07, Vol.28 (19), p.3107-3114

2010

Volltextzugriff (PDF)

Estimating the Prevalence of a True Oligometastatic Disease

Cancers, 2022-12, Vol.15 (1), p.214

2022

Volltextzugriff (PDF)

Anti‐Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance

The oncologist (Dayton, Ohio), 2013-07, Vol.18 (7), p.850-864

2013

Volltextzugriff (PDF)

Editorial: Quality Assessment Across Disciplines in Head and Neck Cancer Treatment

Frontiers in oncology, 2021-02, Vol.11, p.636622-636622

2021

Volltextzugriff (PDF)

Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity

Frontiers in oncology, 2020-05, Vol.10, p.688-688

2020

Volltextzugriff (PDF)

Critical Issues in Head and Neck Oncology: Key Concepts from the Eighth THNO Meeting

1st Edition 2023, 2023

Volltextzugriff (PDF)

Intrapatient Cetuximab Dose Escalation in Metastatic Colorectal Cancer According to the Grade of Early Skin Reactions: The Randomized EVEREST Study

Journal of clinical oncology, 2012-08, Vol.30 (23), p.2861-2868

2012

Volltextzugriff (PDF)

Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer

Cancers, 2023-03, Vol.15 (7), p.1959

2023

Volltextzugriff (PDF)

Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review

Oral oncology, 2016-02, Vol.53, p.10-16

2016

Volltextzugriff (PDF)

1 – 25 von 271

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(262)

Publikationsform

Artikel
(192)
Buchkapitel
(73)
Bücher
(6)

Sprache

Englisch
(271)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(252)
Science & Technology
(252)
Humans
(151)
Female
(80)
Chemotherapy
(63)
Biological And Medical Sciences
(60)
Medical Sciences
(60)
Middle Aged
(60)
Aged
(50)
Adult
(47)
Head And Neck Cancer
(44)
Tumors
(44)
Pharmacology. Drug Treatments
(42)
Male
(39)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(37)
Antineoplastic Agents
(35)
Radiotherapy
(34)
Treatment Outcome
(33)
Head And Neck Neoplasms - Drug Therapy
(32)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher

Management of locally recurrent nasopharyngeal carcinoma

Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum‐based therapies

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group

Editorial: Head and neck cancer in the elderly

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Editorial: Insights in head and neck cancer: 2021

Oligometastatic Cancer: Key Concepts and Research Opportunities for 2021 and Beyond

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study

Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice

A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy

Oligometastatic Disease Management: Finding the Sweet Spot

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer

Estimating the Prevalence of a True Oligometastatic Disease

Anti‐Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance

Editorial: Quality Assessment Across Disciplines in Head and Neck Cancer Treatment

Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity

Critical Issues in Head and Neck Oncology: Key Concepts from the Eighth THNO Meeting

Intrapatient Cetuximab Dose Escalation in Metastatic Colorectal Cancer According to the Grade of Early Skin Reactions: The Randomized EVEREST Study

Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer

Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review

Aktive Filter

Suchergebnisse filtern